Global antiplatelet sales trend: A focus on P2Y12 inhibitors from 2008 to 2018
Background: P2Y12 inhibitors are an important component of dual antiplatelet therapy. Yet, their accessibility and affordability across countries stratified by income levels have not been studied. Methods: Sales data were retrieved from the IQVIA Multinational Integrated Data Analysis System for the...
Main Authors: | Xuxiao Ye, Jessica J.P. Shami, Vincent K.C. Yan, Wei Kang, Joseph E. Blais, Jiaxi Zhao, Wallis C.Y. Lau, Li Wei, Ian C.K. Wong, Esther W. Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | American Heart Journal Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666602221000185 |
Similar Items
-
Complexities of oral antiplatelet drugs use in pregnancy
by: Antonijević Nebojša M., et al.
Published: (2020-01-01) -
Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
by: Oliva A, et al.
Published: (2023-11-01) -
Justice in the Income Tax Collection on Sale-Purchase
by: Dewi Fortuna Limurti
Published: (2022-06-01) -
Sex differences in antiplatelet therapy: state-of-the art
by: Aleksandra Gasecka, et al.
Published: (2023-12-01) -
Basic principles of antiplatelet therapy from the perspective of new recommendations
by: M. G Bubnova, et al.
Published: (2017-12-01)